Page last updated: 2024-08-24

plerixafor and fingolimod hydrochloride

plerixafor has been researched along with fingolimod hydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alari-Pahissa, E; Albentosa, A; Lauzurica, P; Leiva, M; Notario, L; Sabio, G	1

Other Studies

1 other study(ies) available for plerixafor and fingolimod hydrochloride

Article	Year
Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR. Leukemia, 2018, Volume: 32, Issue:6 Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Benzylamines; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Female; Fingolimod Hydrochloride; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Lectins, C-Type; Male; Membrane Proteins; Mice; Phosphoric Monoester Hydrolases; TOR Serine-Threonine Kinases	2018

Article

Year

Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR.

Leukemia, 2018, Volume: 32, Issue:6

Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Benzylamines; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Female; Fingolimod Hydrochloride; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Lectins, C-Type; Male; Membrane Proteins; Mice; Phosphoric Monoester Hydrolases; TOR Serine-Threonine Kinases

2018